Chemoinformaics analysis of Methyl 2-(methylamino)benzoate
| Molecular Weight | 165.192 | nRot | 2 |
| Heavy Atom Molecular Weight | 154.104 | nRig | 7 |
| Exact Molecular Weight | 165.079 | nRing | 1 |
| Solubility: LogS | -2.689 | nHRing | 0 |
| Solubility: LogP | 2.242 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 23 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 11 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 25.0687 |
| nHD | 1 | BPOL | 14.2093 |
| QED | 0.675 |
| Synth | 1.559 |
| Natural Product Likeliness | -0.565 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.364 |
| HIA | 0.005 |
| CACO-2 | -4.501 |
| MDCK | 0.0000439 |
| BBB | 0.717 |
| PPB | 0.735475 |
| VDSS | 0.991 |
| FU | 0.258852 |
| CYP1A2-inh | 0.973 |
| CYP1A2-sub | 0.929 |
| CYP2c19-inh | 0.715 |
| CYP2c19-sub | 0.657 |
| CYP2c9-inh | 0.385 |
| CYP2c9-sub | 0.714 |
| CYP2d6-inh | 0.027 |
| CYP2d6-sub | 0.788 |
| CYP3a4-inh | 0.258 |
| CYP3a4-sub | 0.185 |
| CL | 9.433 |
| T12 | 0.848 |
| hERG | 0.042 |
| Ames | 0.065 |
| ROA | 0.049 |
| SkinSen | 0.285 |
| Carcinogencity | 0.108 |
| EI | 0.975 |
| Respiratory | 0.309 |
| NR-Aromatase | 0.008 |
| Antiviral | No |
| Prediction | 0.874142 |